Patent pool, falsifications and shortages: what COVID19 teaches us about medicines access during a pandemic

Patent pool, falsifications and shortages: what COVID19 teaches us about medicines access during a pandemic

The performance of health systems is at the center of the attention during the coronavirus disease (COVID-19) pandemic. As part of health systems performance, equitable access to quality care including medicines, vaccines and diagnostics has become critical linchpin in the response to the pandemic.

The guest speaker Dr. Jonathan Quick is a family physician and public health management specialist that focuses on global health security. He is adjunct professor of global health at Duke University in North Carolina. His book “The End of Epidemics: The Looming Threat to Humanity and How to Stop” was published in 2018. In April 2020 he has been appointed as the Managing Director for Pandemic Response, Preparedness and Prevention at The Rockefeller Foundation.

Moderate by Prof. Veronika Wirtz, co-chair of the Medicines in Health Systems Thematic Working Group, this webinar explores the challenges of equitable access to existing and new medicines and technologies during the pandemic and the lessons learned.

—

Image credit: Allison Turrell, Creative Commons license 2.0